These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 32360)

  • 61. Mechanism of decreased vascular reactivity to angiotensin II in conscious, potassium-deficient rats.
    Paller MS; Douglas JG; Linas SL
    J Clin Invest; 1984 Jan; 73(1):79-86. PubMed ID: 6690484
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Binding, degradation and pressor activity of angiotensins II and III after aminopeptidase inhibition with amastatin and bestatin.
    Abhold RH; Sullivan MJ; Wright JW; Harding JW
    J Pharmacol Exp Ther; 1987 Sep; 242(3):957-62. PubMed ID: 3656120
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Receptor binding interactions of the angiotensin II antagonist, 125I-[sarcosine1,leucine8]angiotensin II, with mammalian brain and peripheral tissues.
    Bennett JP; Snyder SH
    Eur J Pharmacol; 1980 Oct; 67(1):11-25. PubMed ID: 6252019
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Regulation of receptor binding interactions of 125I-angiotensin II and 125I-[sarcosine1,leucine8]angiotensin II, an angiotensin antagonist, by sodium ion.
    Bennett JP; Snyder SH
    Eur J Pharmacol; 1980 Oct; 67(1):1-10. PubMed ID: 6252018
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In vivo pharmacology of a novel AT1 selective angiotensin II receptor antagonist, MK-996.
    Kivlighn SD; Zingaro GJ; Gabel RA; Broten TP; Schorn TW; Schaffer LW; Naylor EM; Chakravarty PK; Patchett AA; Greenlee WJ
    Am J Hypertens; 1995 Jan; 8(1):58-66. PubMed ID: 7734099
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Attenuation by naloxone of the pressor effects of angiotensin II in conscious cynomolgus monkeys.
    Kirby DA; Spealman RD
    Life Sci; 1988; 43(5):453-8. PubMed ID: 3398708
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Chronic estradiol treatment decreases angiotensin II receptor density in the anterior pituitary gland and adrenal cortex but not in the mesenteric artery.
    Carrière PD; De Léan A; Gutkowska J; Genest J; Cantin M
    Neuroendocrinology; 1986; 43(1):49-56. PubMed ID: 3012393
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Centrally administered insulin potentiates the pressor response to angiotensin II.
    Mayer MA; Giani JF; Höcht C; Silberman EA; Muñoz MC; Taira CA; Dominici FP; Puyó AM; Fernández BE
    Regul Pept; 2010 Aug; 163(1-3):57-61. PubMed ID: 20433878
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prolonged inhibition of angiotensin II attenuates glycerol-induced acute renal failure.
    Abdulkader RC; Yuki MM; Paiva AC; Marcondes M
    Braz J Med Biol Res; 1988; 21(2):233-9. PubMed ID: 3203159
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Lack of specific inhibition of angiotensin II in eels by angiotensin antagonists.
    Nishimura H; Norton VM; Bumpus FM
    Am J Physiol; 1978 Jul; 235(1):H95-103. PubMed ID: 677333
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A dynamic model of angiotensin II infusion experiments.
    White KP; Radke-Sharpe NF; Kaiser DL; Owens GK
    J Biomed Eng; 1989 Jan; 11(1):63-71. PubMed ID: 2648070
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Research note: naloxone inhibits drinking in the chick induced by angiotensin II.
    Firman JD; Volmert RF
    Poult Sci; 1991 Sep; 70(9):2010-2. PubMed ID: 1780271
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inhibition of pressor effects of angiotensin I and augmentation of depressor effects of bradykinin by synthetic peptides.
    Engel SL; Schaeffer TR; Gold BI; Rubin B
    Proc Soc Exp Biol Med; 1972 May; 140(1):240-4. PubMed ID: 4338183
    [No Abstract]   [Full Text] [Related]  

  • 74. Hyperglycemic action of angiotensin II in freely moving rats.
    Machado LJ; Mihessen-Neto I; Marubayashi U; Reis AM; Coimbra CC
    Peptides; 1995; 16(3):479-83. PubMed ID: 7651902
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Angiotensin antagonist and possible release of catecholamine.
    Sen S; Smeby RR; Bumpus FM
    Proc Soc Exp Biol Med; 1974 Dec; 147(3):847-9. PubMed ID: 4374706
    [No Abstract]   [Full Text] [Related]  

  • 76. Angina-like pain: an unexpected side-effect following the simultaneous administration of angiotensin II and prostaglandin E2 in normal adults.
    Broughton Pipkin F; Turner SR; O'Brien PM
    Prostaglandins Med; 1981 Jan; 6(1):9-11. PubMed ID: 7220655
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Long-lasting inhibition of angiotensin response in rats by depot administration of octanoyl-[Leu8]-angiotensin II.
    Abdulkader RC; Silva HB; Marcondes M; Vasconcelos EA; Paiva AC
    J Pharm Pharmacol; 1979 Jan; 31(1):20-2. PubMed ID: 32360
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Selective pharmacological effects of triprolyl and pentasarcosyl angiotensin II.
    Mikami H; Ogihara T; Katahira K; Imai N; Kumahara Y; Bumpus FM; Khosla MC
    J Cardiovasc Pharmacol; 1987 Feb; 9(2):242-5. PubMed ID: 2436006
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Synthesis of octanoyl[8-leucyl]angiotensin II, a lipophilic angiotensin antagonist.
    Paiva AC; Nouailhetas VL; Paiva TB
    J Med Chem; 1977 Jul; 20(7):898-901. PubMed ID: 874965
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of inhibition of central angiotensin pressor mechanisms on blood pressure in spontaneously hypertensive rats.
    Bruner CA; Kuslikis BI; Fink GD
    J Cardiovasc Pharmacol; 1987 Mar; 9(3):298-304. PubMed ID: 2437396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.